8-K ·Filed May 5, 2026

ATRC

AtriCure, Inc.
MIXED
Impact 6/10
Horizondays Processed5mo ago SEC0001323885-26-000018
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The sharp reduction in adjusted EPS guidance despite a strong quarter signals potential margin pressure or increased spending. Watch Q2 2026 results for confirmation of cost trends. The stock may sell off on the guidance cut, but the underlying revenue momentum suggests any dip could be a buying opportunity if margins stabilize.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ATRC ▲ +34.81% at T+60d
NEUTRAL call ✓ call won +34.81% · α vs SPY +32.75% · entry $28.01 → $37.76
Entry anchored
May 5, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α +0.33%
$28.01
settled 5mo ago
T+5d
-4.71%
call -4.71% · α -5.84%
$26.69
settled 5mo ago
T+20d
-6.46%
call -6.46% · α -9.24%
$26.20
settled 4mo ago
T+60d
+34.81%
call +34.81% · α +32.75%
$37.76
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

AtriCure reported Q1 2026 revenue of $141.2M (+14.3% YoY) and achieved GAAP net income of $0.1M, beating EPS consensus of -$0.07. However, full-year 2026 adjusted EPS guidance was slashed from $0.09-$0.15 to $0.00-$0.04, overshadowing the strong quarter.

Key Financial Metrics

EPS
$0.00
est $-0.07 · +100.0%
Revenue
$141.2M
+14.3% YoY
Rating
beat
Guidance
$600M-$610M
lowered
Gross Margin
77.4%

Key Facts

  • Q1 2026 revenue $141.2M, +14.3% YoY (12.8% constant currency)
  • Gross margin expanded 246 bps to 77.4%
  • GAAP net income $0.1M vs loss of $6.7M YoY; EPS $0.00 vs consensus -$0.07
  • Adjusted EBITDA $17.1M, +95% YoY
  • FY2026 revenue guidance reaffirmed at $600-$610M
  • FY2026 adjusted EPS guidance lowered from $0.09-$0.15 to $0.00-$0.04

Financial Impact

Guidance cut on EPS from $0.09-$0.15 to $0.00-$0.04 implies ~70% midpoint decline; revenue guidance unchanged.

epsguidance

Risk Factors

  • Full-year EPS guidance cut significantly lower; margin compression risk
  • Selling, general & administrative expenses grew 11% YoY, outpacing revenue growth
  • Historical stock reaction to earnings has been negative (last report down -2% at T+20)

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001323885-26-000018
Document: atrc-20260505.htm0001323885-26-000018
Document: 0001323885-26-000018-index-headers.html0001323885-26-000018
Document: 0001323885-26-000018-index.html0001323885-26-000018
Document: 0001323885-26-000018.txt0001323885-26-000018
8-K Data (Synthetic)0001323885-26-000018
10 reports for ATRC
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +89.53%Jun 14, 2026
Filters
Rows
Reports for ATRC — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$55.79 $58.32▲ +4.53%▲ +2.88%$55.14 (−1.17%)
Aug 7, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$41.39 $44.30▲ +7.03%▲ +6.63%$55.14 (+33.22%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.15 $39.49▼ −1.64%▼ −5.27%$55.14 (+37.33%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.15 $39.49▼ −1.64%▼ −5.27%$55.14 (+37.33%)
Jul 23, 2026
10w ago
8-K
BULLISH ★ 6/10
$35.04 $40.15▲ +14.58%▲ +14.21%$55.14 (+57.36%)
Jun 14, 2026
15w ago
Institutional Cluster
BULLISH ★ 5/10
$27.98 $28.44▲ +1.64%▲ +3.03%$55.14 (+97.07%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$28.41 $27.12▲ +4.54%▲ +4.97%$55.14 (−94.09%)
May 22, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$28.29 $26.48▼ −6.40%▼ −8.07%$55.14 (+94.91%)
May 5, 2026
21w ago
8-K
MIXED ★ 6/10
$28.01 $26.69▼ −4.71%▼ −5.84%$55.14 (+96.86%)
Apr 6, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$29.19 $28.66▼ −1.82%▼ −5.95%$55.14 (+88.90%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (38h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access